J Nephropathol. 2019;8(4):34-34.
doi: 10.15171/jnp.2019.34
  Abstract View: 93
  PDF Download: 52

Editorial

The use of modified Ponticelli regimens for primary membranous nephropathy

Macaulay Amechi Chukwukadibia Onuigbo 1,2 *

1 The Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT, USA
2 College of Business, University of Wisconsin MBA Consortium, Eau Claire, WI, USA
*Corresponding author: Macaulay Amechi Chukwukadibia Onuigbo, Email: Email: macaulay.onuigbo@uvmhealth.org

Implication for health policy/practice/research/medical education:

Given the comparable efficacy of the modified-‘modified Ponticelli’ regimens using lower doses of cyclophosphamide and corticosteroids, respectively, and cognizant of the natural history of primary membranous nephropathy (MN), every effort to mitigate the deleterious adverse effects of immunosuppression, while still not losing therapeutic efficacy in the management of primary MN, must continue to be encouraged.

Please cite this paper as: Onuigbo MAC. The use of modified Ponticelli regimens for primary membranous nephropathy. J Nephropathol. 2019;8(4):e34. DOI: 10.15171/jnp.2019.34.

First name
 
Last name
 
Email address
 
Comments
 
Security code


Article Viewed: 93

Your browser does not support the canvas element.


PDF Downloaded: 52

Your browser does not support the canvas element.

Submitted: 26 Sep 2019
Accepted: 10 Oct 2019
First published online: 18 Oct 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)